Product
Mixture 3,6% H2 in N2
1 clinical trial
1 indication
Indication
COVID-19Clinical trial
Hydrogen Inhalation Therapy in Patients With Moderate Covid-19: Phase-1 Clinical TrialStatus: Completed, Estimated PCD: 2022-06-30
1 clinical trial
1 indication